-
SRGAQ Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Surgalign (SRGAQ)
Company Profile
Quarter (USD) | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 22.43 mm | 22.43 mm | 22.43 mm | 22.43 mm | 22.43 mm | 22.43 mm |
Cash burn (monthly) | (no burn) | 1.85 mm | (no burn) | 5.59 mm | 3.01 mm | 3.50 mm |
Cash used (since last report) | n/a | 42.52 mm | n/a | 128.16 mm | 68.97 mm | 80.25 mm |
Cash remaining | n/a | -20.09 mm | n/a | -105.73 mm | -46.54 mm | -57.82 mm |
Runway (months of cash) | n/a | -10.8 | n/a | -18.9 | -15.5 | -16.5 |
13F holders | Current |
---|---|
Total holders | 3 |
Opened positions | 1 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 17.73 mm |
Total shares | 9.49 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Roboticine | 6.25 mm | $10.63 mm |
Glen Capital Partners Focus Fund | 3.24 mm | $7.10 mm |
Proequities | 0.00 | $0.00 |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Sep 23 | Lyle David | Common Stock | Payment of exercise | Dispose F | No | No | 0.01 | 1,329 | 13.29 | 83,307 |
1 Sep 23 | Paolo Amoruso | Common Stock | Payment of exercise | Dispose F | No | No | 0.01 | 2,191 | 21.91 | 28,809 |